Advances in Treatment of Waldenström Macroglobulinemia

被引:0
|
作者
Eric Durot
Cécile Tomowiak
机构
[1] CHU de Reims Et UFR Médecine,Hématologie Clinique
[2] CHU de Poitiers,Service d’Onco
来源
Current Oncology Reports | 2023年 / 25卷
关键词
Waldenström macroglobulinemia; mutation; Chemoimmunotherapy; BTK inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1375 / 1386
页数:11
相关论文
共 50 条
  • [41] MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
    Xu, Lian
    Hunter, Zachary R.
    Yang, Guang
    Zhou, Yangsheng
    Cao, Yang
    Liu, Xia
    Morra, Enrica
    Trojani, Alessandra
    Greco, Antonino
    Arcaini, Luca
    Varettoni, Marzia
    Brown, Jennifer R.
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    Patterson, Christopher J.
    Manning, Robert J.
    Tripsas, Christina K.
    Lindeman, Neal I.
    Treon, Steven P.
    BLOOD, 2013, 121 (11) : 2051 - 2058
  • [42] Mutational change of CTX-M-15 to CTX-M-127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient
    Nielsen, Karen Leth
    Hansen, Katrine Hartung
    Nielsen, Jesper Boye
    Knudsen, Jenny Dahl
    Schonning, Kristian
    Frimodt-Moller, Niels
    Hertz, Frederik Boetius
    Jansaker, Filip
    MICROBIOLOGYOPEN, 2019, 8 (12):
  • [44] 3M syndrome: Evaluating the clinical and laboratory features and the response of the growth hormone treatment: Single center experience
    Kucukali, Guelin Karacan
    Keskin, Meliksah
    Aycan, Zehra
    Savas-Erdeve, Senay
    Cetinkaya, Semra
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2023, 66 (10)
  • [45] Pioglitazone and Deoxyribonucleoside Combination Treatment Increases Mitochondrial Respiratory Capacity in m.3243A>G MELAS Cybrid Cells
    Burgin, Harrison J.
    Sanchez, M. Isabel G. Lopez
    Smith, Craig M.
    Trounce, Ian A.
    McKenzie, Matthew
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [46] The safety and efficacy of osimertinib for the treatment of EGFR T790M mutation positive non-small-cell lung cancer
    Gao, Xin
    Le, Xiuning
    Costa, Daniel B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 383 - 390
  • [47] Treatment Management Challenges in Naïve and Experienced HIV-1-Infected Individuals Carrying the M184V Mutation
    Mimtsoudis, Iordanis
    Tsachouridou, Olga
    Akinosoglou, Karolina
    Metallidis, Symeon
    VIRUSES-BASEL, 2024, 16 (09):
  • [48] Meta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber hereditary optic neuropathy
    Newman, Nancy J.
    Biousse, Valerie
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Vignal-Clermont, Catherine
    Montestruc, Francois
    Taiel, Magali
    Sahel, Jose-Alain
    SURVEY OF OPHTHALMOLOGY, 2025, 70 (02) : 283 - 295
  • [49] Are we ready to introduce T790M plasma analysis in the follow up of patients with NSCLC under treatment with EGFR-TKI?
    Alegre, Estibaliz
    Martinez, Debora
    Macias, Monica
    Gonzalez, Alvaro
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (24)
  • [50] m.4216 T > C polymorphism in JT cluster determines a lower pregnancy rate in response to controlled ovarian stimulation treatment
    Monge-Ochoa, Belen
    Montoro, Luis
    Montoya, Julio
    Ruiz-Pesini, Eduardo
    Lopez-Perez, Manuel J.
    de Castro, Francisco
    Diez-Sanchez, Carmen
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2023, 40 (03) : 671 - 682